NCT06950385 2026-03-17
SERENTA
Rapamycin Holdings Inc.
Phase 3 Recruiting
Clinical Trials
5 trialsNCT06545526 2024-08-09
Chemopreventive Effect of Combination of Celecoxib and Metformin in Patients With Familial Adenomatous Polyposis
Yonsei University
Phase 3 Recruiting
NCT01483144 2021-06-08
Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP)
Cancer Prevention Pharmaceuticals, Inc.
Phase 3 Completed
NCT00585312 2021-02-21
CHIP
Pfizer
Phase 3 Terminated
NCT01245816 2015-04-24
A Trial of Low Dose Sulindac Combined With Eflornithine in Patients With Familial Adenomatous Polyposis (FAP)
Cancer Prevention Pharmaceuticals, Inc.
Phase 3 Withdrawn